pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
NOVARTIS · news · pharmadog
← back to NOVARTIS
News mentioning NOVARTIS
86
stories
Jun 11, 26
Novartis RNA drug acquired in $12B Avidity deal notches a trial win
biopharma dive
Jun 11, 26
STAT+: Novartis doubles down on molecular glue strategy
stat
Jun 11, 26
J&J looks to widen Imaavy’s use; $300M backs rare disease drug launch
biopharma dive
Jun 11, 26
STAT+: Enliven Therapeutics’ leukemia drug shows promise in new study
stat
Jun 10, 26
Novartis and Orionis strike second molecular glue deal for $40M upfront
endpoints
Jun 8, 26
Incyte to buy blood disorder drug in possibly $2B deal
biopharma dive
Jun 3, 26
Legend surges on early data for ‘in vivo’ lymphoma cell therapy
biopharma dive
Jun 2, 26
Celcuity breast cancer drug misses ‘lofty’ expectations in ASCO-spotlighted trial
biopharma dive
Jun 2, 26
Fulcrum exploring a potential sale after FDA sidelined its sickle cell drug
biopharma dive
Jun 2, 26
Male contraception startup closes $92.5M Series B; Novartis bets on actinium
endpoints
May 19, 26
STAT+: Pharmalittle: We’re reading about a Supreme Court setback for pharma, TrumpRx expands and much more
stat
May 19, 26
Relay drug shows early promise against rare blood vessel diseases
biopharma dive
May 18, 26
STAT+: Supreme Court rejects challenge to Medicare drug price negotiation
stat
May 13, 26
Assertio accepts new buyout bid; AI biotech Isomorphic banks $2B
biopharma dive
May 8, 26
Post–T-DXd Sacituzumab Govitecan Plus Trastuzumab Yields Low ORR in HER2+ Metastatic Breast Cancer
onclive
May 8, 26
Capivasertib/Fulvestrant Yields Numerical OS Advantage in PIK3CA/AKT1/PTEN–Altered Breast Cancer
onclive
May 7, 26
Entrada shares dive as Duchenne results disappoint
biopharma dive
May 7, 26
Amgen adds $300M to Puerto Rico budget; Novartis to exit oral drug factory in Germany
endpoints
May 4, 26
Celcuity strengthens case for ASCO-spotlighted breast cancer drug
biopharma dive
Apr 30, 26
Merck still sees ‘compelling’ outlook for Terns leukemia drug
biopharma dive
Apr 30, 26
STAT+: Five-way obesity drug is super effective — in mice
stat
Apr 30, 26
Novartis unveils North Carolina factory as final new build in $23B US expansion
endpoints
Apr 28, 26
STAT+: Boehringer’s obesity drug shows 16.6% weight loss; more data needed
stat
Apr 28, 26
STAT+: Pharmalittle: We’re reading about warnings over Trump’s MFN plan, Purdue Pharma sentencing, and more
stat
Apr 28, 26
Novartis CEO disheartened by Germany’s planned €60B cuts to healthcare spending
endpoints
Dec 23, 25
Fierce Biotech Layoff Tracker 2026: Amgen sheds staff; Clinuvel cuts fifth of workforce
fiercebiotech
← prev
page 3 of 3
next →
